203
Participants
Start Date
July 31, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
CR845
Single i.v. dose (0.04 mg/kg) administered preoperatively
Placebo
Single i.v. dose administered preoperatively
CR845
Single i.v. dose (0.04 mg/kg) administered postoperatively for pain
Placebo
Single i.v. dose administered postoperatively for pain
Duke University, Durham
Palmetto Clinical Research,, Greenville
Riverside Clinical Research, Edgewater
University of Miami, Dept of, Miami
Visions Clinical Research, Boynton Beach
Shoals Clinical Research Associates, Florence
Shoals Medical Trials, INC, Sheffield
Drug Research and Analysis Corp, Montgomery
Horizon Research Group, Mobile
Wilmax, Mobile
Chattanooga Medical Research, Chattanooga
Ohio State University Medical, Dept of Anesthesia, Columbus
Cypress Medical Research, Wichita
Texas Health Care, PLLC, Fort Worth
Precision Clinical Trials, Phoenix
Olive View-UCLA Medical Center, Sylmar
Woodland Healthcare California Clinical Research, Inc, Davis
Cooper University Hospital, Camden
Lead Sponsor
Cara Therapeutics, Inc.
INDUSTRY